Welcome to our dedicated page for Gold River Prod news (Ticker: GRPS), a resource for investors and traders seeking the latest updates and insights on Gold River Prod stock.
Trans American Aquaculture, Inc. (GRPS) reports developments tied to its sustainable shrimp aquaculture business, including pond stocking, harvest cycles, shrimp sales, production planning, and quality or health-inspection updates. Company updates also cover its efforts to operate as a public issuer following a reverse merger into the GRPS ticker.
Recurring news themes include audited financial statements, SEC reporting progress, capital needs for aquaculture operations and equipment, authorized-share actions, governance additions, and work related to ticker and corporate-name alignment. The company describes its products as responsibly raised, U.S.-grown farm-raised shrimp for seafood buyers and retail distribution.
Gold River Productions (OTC Pink: GRPS) launched the 1001 Veterans Relief Program in collaboration with Epidemiologic Solutions, aiming to provide urgent relief products for veterans facing issues like discomfort, sleep problems, and anxiety. The initiative includes a kit with seven products, such as Relief Gummies and Relax Cream. The company is positioned as a non-consortia participant for DOD-OT and is actively seeking purchase orders from various commands. The campaign also targets income generation while enhancing product visibility through social media marketing.
Gold River Productions, Inc. (OTC Pink: GRPS) appoints Dr. Gabe Vlad as Chief Technical Officer, enhancing its leadership in algorithm development and advanced research. Dr. Vlad brings extensive experience with government contracts, aiming to create innovative health solutions, including an alternative medicine cookbook. He emphasizes shareholder value and anticipates improving medical approaches through a user-friendly health platform, promising benefits for veterans and more. Gold River continues its commitment to developing herbal health products targeting various conditions, with several new items in the pipeline.
Gold River Productions, Inc. (OTC Pink: GRPS) announces the production of its new product line, including Inflammaplex, Painplex, Energyplex, and Longevityplex, aimed at enhancing patient wellness. The products, expected to launch in spring 2022, are designed to provide alternatives to pharmaceuticals, focusing on effective herbal extracts. The production run will yield 40,000 units at a cost of around $560,000, with projected retail value at approximately $2.4 million. Executives emphasize the effectiveness of these nutraceuticals, positioning them as game-changers in the market.
Gold River Productions (OTC Pink: GRPS) announced its successful registration as a United States Government contractor, allowing engagement with various federal departments for its products and services. This milestone was confirmed via the System Award Management (SAM) registration, enabling the company to pursue government contracting directly. Executives highlighted the significance of this achievement in meeting the needs of active and retired military personnel who may benefit from the company's herbal-based products aimed at improving quality of life.
Gold River Productions (OTC Pink: GRPS) has finalized a marketing and distribution agreement with VirExit Technologies (OTC Pink: VXIT) to enhance its reach to consumer and business customers. This partnership focuses on wellness, health, productivity, and safety, promoting product credibility through curated offerings. Key products include Inflammaplex, Painplex, and Energyplex, which have completed R&D phases and are set for mass market availability. The collaboration aims to provide unique solutions by combining consumer experiences with innovative marketing techniques.
Gold River Productions, Inc. (OTC Pink: GRPS) announced the opening of its Rejuvenation Division and the appointment of Michael Berkowitz to lead it. Berkowitz brings extensive experience in cell-based therapy, aimed at enhancing the company's herbal formulations. The global stem cells market is expected to grow significantly, with a projected CAGR of 12.8% from $11.90 billion in 2021 to $27.65 billion in 2028. GRPS plans to establish StemSpa facilities to offer innovative treatments and educational resources to physicians, potentially transforming patient care.
Gold River Productions, Inc. (OTC Pink: GRPS) is expanding its product offerings into the pet care market, which is expected to reach a size of $325.74 billion by 2028. Joining the team is Dr. Danielle Morosco, who will lead the veterinary division and brings extensive experience with domestic and larger animals. The company is developing a unique pain and anxiety formulation for pets, utilizing rare cannabinoids. Dr. Morosco's insights into the formulation aim to enhance its anti-inflammatory effects while maintaining affordability.
Gold River Productions (OTC Pink: GRPS) is set to launch sales and distribution of three unique nutraceutical supplements and its inaugural gummy line through distributor All Star Health Brands Inc. This expansion will reach international markets, including Jamaica, Canada, and parts of Latin America within six months. Dr. Richard Goulding, Chairman, expressed excitement over product readiness and confirmed a partnership with Eden Labs, ensuring high quality. The new formulations aim to provide effective health solutions without sugar or caffeine. Note: Products have not been evaluated by the FDA.